p.100 抽出テキスト

Valve Collaboratory expert consensus document on operative techniques. J Thorac Cardiovasc Surg 2024;169:878–89. https://doi.org/10.1016/j.jtcvs.2024.04.025 898. Bleiziffer S, Rudolph TK. Patient prosthesis mismatch after SAVR and TAVR. Front Cardiovasc Med 2022;9:761917. https://doi.org/10.3389/fcvm.2022.761917 899. Hirji SA, Percy ED, Zogg CK, Malarczyk A, Harloff MT, Yazdchi F, et al. Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes. Eur Heart J 2020;41:2747–55. https://doi.org/10.1093/ eurheartj/ehaa252 900. Tam DY, Vo TX, Wijeysundera HC, Dvir D, Friedrich JO, Fremes SE. Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2018;92:1404–11. https://doi.org/10.1002/ccd.27686 901. Bleiziffer S, Simonato M, Webb JG, Rodes-Cabau J, Pibarot P, Kornowski R, et al. Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves. Eur Heart J 2020;41:2731–42. https://doi.org/10.1093/eurheartj/ehaa544 902. Guerrero M, Vemulapalli S, Xiang Q, Wang DD, Eleid M, Cabalka AK, et al. Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States: data from the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv 2020;13:e008425. https://doi.org/10. 1161/CIRCINTERVENTIONS.119.008425 903. Eleid MF, Whisenant BK, Cabalka AK, Williams MR, Nejjari M, Attias D, et al. Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv 2017;10:1932–42. https://doi.org/10.1016/j.jcin.2017.08. 014 904. Little SH, Bapat V, Blanke P, Guerrero M, Rajagopal V, Siegel R. Imaging guidance for transcatheter mitral valve intervention on prosthetic valves, rings, and annular calcification. JACC Cardiovasc Imaging 2021;14:22–40. https://doi.org/10.1016/j.jcmg.2019.10. 027 905. Fallon JM, DeSimone JP, Brennan JM, O’Brien S, Thibault DP, DiScipio AW, et al. The incidence and consequence of prosthesis-patient mismatch after surgical aortic valve replacement. Ann Thorac Surg 2018;106:14–22. https://doi.org/10.1016/j.athoracsur. 2018.01.090 906. Flameng W, Herregods MC, Vercalsteren M, Herijgers P, Bogaerts K, Meuris B. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation 2010;121:2123–9. https://doi.org/10.1161/ CIRCULATIONAHA.109.901272 907. Zorn GLI, Little SH, Tadros P, Deeb GM, Gleason TG, Heiser J, et al. Prosthesis–patient mismatch in high-risk patients with severe aortic stenosis: a randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg 2016;151:1014–23.e3, 1023.e1011–1013. https://doi.org/10.1016/j.jtcvs.2015.10.070 908. Thourani VH, Abbas AE, Ternacle J, Hahn RT, Makkar R, Kodali SK, et al. Patient-prosthesis mismatch after surgical aortic valve replacement: analysis of the PARTNER trials. Ann Thorac Surg 2024;117:1164–71. https://doi.org/10.1016/j. athoracsur.2024.01.023 909. Tomii D, Okuno T, Heg D, Nakase M, Lanz J, Praz F, et al. Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement. EuroIntervention 2023;19:746–56. https://doi.org/10.4244/eij-d-23- 00456 910. Vriesendorp MD, De Lind Van Wijngaarden RAF, Head SJ, Kappetein AP, Hickey GL, Rao V, et al. The fallacy of indexed effective orifice area charts to predict prosthesis– patient mismatch after prosthesis implantation. Eur Heart J Cardiovasc Imaging 2020;21: 1116–22. https://doi.org/10.1093/ehjci/jeaa044 911. Sorajja P, Bae R, Lesser JA, Pedersen WA. Percutaneous repair of paravalvular prosthetic regurgitation: patient selection, techniques and outcomes. Heart 2015;101: 665–73. https://doi.org/10.1136/heartjnl-2014-306270 912. Ruiz CE, Hahn RT, Berrebi A, Borer JS, Cutlip DE, Fontana G, et al. Clinical trial principles and endpoint definitions for paravalvular leaks in surgical prosthesis. Eur Heart J 2018;39:1224–45. https://doi.org/10.1093/eurheartj/ehx211 913. Laplace G, Lafitte S, Labèque JN, Perron JM, Baudet E, Deville C, et al. Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients. J Am Coll Cardiol 2004;43:1283–90. https://doi. org/10.1016/j.jacc.2003.09.064 914. Symersky P, Budde RPJ, de Mol BAJM, Prokop M. Comparison of multidetector-row computed tomography to echocardiography and fluoroscopy for evaluation of patients with mechanical prosthetic valve obstruction. Am J Cardiol 2009;104:1128–34. https://doi.org/10.1016/j.amjcard.2009.05.061 915. Egbe AC, Pislaru SV, Pellikka PA, Poterucha JT, Schaff HV, Maleszewski JJ, et al. Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. J Am Coll Cardiol 2015;66:2285–94. https://doi.org/10.1016/j.jacc.2015.09. 022 916. Rheude T, Pellegrini C, Stortecky S, Marwan M, Xhepa E, Ammon F, et al. Meta-analysis of bioprosthetic valve thrombosis after transcatheter aortic valve implantation. Am J Cardiol 2021;138:92–9. https://doi.org/10.1016/j.amjcard.2020.10.018 917. Blanke P, Leipsic JA, Popma JJ, Yakubov SJ, Deeb GM, Gada H, et al. Bioprosthetic aortic valve leaflet thickening in the Evolut Low Risk sub-study. J Am Coll Cardiol 2020;75: 2430–42. https://doi.org/10.1016/j.jacc.2020.03.022 918. Chakravarty T, Sondergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet 2017;389:2383–92. https://doi.org/10.1016/S0140- 6736(17)30757-2 919. Makkar RR, Blanke P, Leipsic J, Thourani V, Chakravarty T, Brown D, et al. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy. J Am Coll Cardiol 2020;75:3003–15. https://doi. org/10.1016/j.jacc.2020.04.043 920. De Backer O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, et al. Reduced leaflet motion after transcatheter aortic-valve replacement. N Engl J Med 2020;382:130–9. https://doi.org/10.1056/NEJMoa1911426 921. Montalescot G, Redheuil A, Vincent F, Desch S, De Benedictis M, Eltchaninoff H, et al. Apixaban and valve thrombosis after transcatheter aortic valve replacement: the ATLANTIS-4D-CT randomized clinical trial substudy. JACC Cardiovasc Interv 2022; 15:1794–804. https://doi.org/10.1016/j.jcin.2022.07.014 922. Ruile P, Jander N, Blanke P, Schoechlin S, Reinöhl J, Gick M, et al. Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation. Clin Res Cardiol 2017;106:85–95. https://doi.org/10.1007/s00392- 016-1052-3 923. Günduz S, Özkan M, Kalçik M, Gürsoy OM, Astarcioglu MA, Karakoyun S, et al. Sixty-four-section cardiac computed tomography in mechanical prosthetic heart valve dysfunction: thrombus or pannus. Circ Cardiovasc Imaging 2015;8:e003246. https://doi. org/10.1161/CIRCIMAGING.115.003246 924. Lancellotti P, Pibarot P, Chambers J, Edvardsen T, Delgado V, Dulgheru R, et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2016;17:589–90. https://doi.org/10.1093/ehjci/jew025 925. Tanis W, Habets J, van den Brink RBA, Symersky P, Budde RP, Chamuleau SA. Differentiation of thrombus from pannus as the cause of acquired mechanical prosthetic heart valve obstruction by non-invasive imaging: a review of the literature. Eur Heart J Cardiovasc Imaging 2014;15:119–29. https://doi.org/10.1093/ehjci/jet127 926. Karthikeyan G, Senguttuvan NB, Joseph J, Devasenapathy N, Bahl VK, Airan B. Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies. Eur Heart J 2013;34:1557–66. https://doi.org/10.1093/eurheartj/ehs486 927. Castilho FM, De Sousa MR, Mendonca AL, Ribeiro AL, Caceres-Loriga FM. Thrombolytic therapy or surgery for valve prosthesis thrombosis: systematic review and meta-analysis. J Thromb Haemost 2014;12:1218–28. https://doi.org/10.1111/jth. 12577 928. Chopard R, Vidoni C, Besutti M, Ismail M, Ecarnot F, Favoulet B, et al. Surgery versus thrombolytic therapy for the management of left-sided prosthetic valve thrombosis without hemodynamic compromise: a systematic review and meta-analysis. J Am Heart Assoc 2024;13:e035143. https://doi.org/10.1161/jaha.124.035143 929. Özkan M, Günduz S, Güner A, Kalcik M, Gursoy MO, Uygur B, et al. Thrombolysis or surgery in patients with obstructive mechanical valve thrombosis: the multicenter HATTUSHA study. J Am Coll Cardiol 2022;79:977–89. https://doi.org/10.1016/j.jacc. 2021.12.027 930. Özkan M, Günduz S, Gürsoy OM, Karakoyun S, Astarcioglu MA, Kalcik M, et al. Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve thrombosis and the prEdictors of outcomE: the ultra-slow PROMETEE trial. Am Heart J 2015;170:409–18. https://doi.org/10.1016/j.ahj.2015.04. 025 931. Sadeghipour P, Saedi S, Saneei L, Rafiee F, Yoosefi S, Parsaee M, et al. Fast vs. ultraslow thrombolytic infusion regimens in patients with obstructive mechanical prosthetic valve thrombosis: a pilot randomized clinical trial. Eur Heart J Cardiovasc Pharmacother 2022;8:668–76. https://doi.org/10.1093/ehjcvp/pvab083 931a. Karthikeyan G, Rajashekar P, Devasenapathy N, Biswas S, Kidambi B, Singal A, et al. Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial. Eur Heart J 2025;46:3373–81. https://doi.org/10.1093/eurheartj/ehaf391 932. Bemurat LR, Laffort PR, Deville CJ, Roques XG, Baudet EM, Roudaut RP. Management of nonobstructive thrombosis of prosthetic mitral valve in asymptomatic patients in the early postoperative period: a study in 20 patients. Echocardiography 1999;16: 339–46. https://doi.org/10.1111/j.1540-8175.1999.tb00823.x 933. Mutuberría-Urdaniz M, Rodríguez-Palomares JF, Ferreira I, Bañeras J, Teixidó G, Gutiérrez L, et al. Non-obstructive prosthetic heart valve thrombosis (NOPVT): really a benign entity? Int J Cardiol 2015;197:16–22. https://doi.org/10.1016/j.ijcard.2015.06. 021 Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026